Acquire the insider country intelligence to execute successful strategies Belgium Pharma Report Belgium is in fact still the world’s second largest exporter of pharmaceuticals. As such, the pharmaceutical industry is a significant positive contributor to the country’s trade balance. Today, the Belgian pharmaceutical market is valued at approximately US 6.1 billion and is supported by “a highly commendable healthcare system which provides a high stand of services to patients.” The country is regarded as a hub for clinical trials, a leader in the biopharmaceutical industry and a hub for pharmaceutical production and distribution. Brazil Pharma Report Last to enter the financial crisis and first to emerge, Brazil has created a new block of middle-class “pharmerging” consumers. Learn key drivers with rapid growth in this ninth-largest market. Report includes key economic data, interviews and company directory. China Pharma Report Favorable government policies towards healthcare and innovation are driving a 20%+ compounded annual growth rate in this market. Learn key drivers with rapid growth in the third-largest worldwide pharmaceutical market. Report includes key economic data and interviews. Colombia Pharma Report Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. Thanks to the ratification of free trade agreements with 14 countries around the world since 2011, including the United States, foreign direct investment reached a record high of COP 29 trillion (USD 16 billion) in 2012. While this is good news for the pharmaceutical industry, there is still a strong debate about how healthcare in Colombia can be improved. While Colombia enjoys near-universal coverage, a feat rarely seen in Latin America, the financial strain caused by this broad coverage has created the need for change. The industry is watching as the country enters a period of transformation. Written after exclusive interviews with the country’s decision makers from local and multinational companies, manufacturers, distributors, experts, legislators, this is a unique resource for those looking beyond figures. Ireland Pharma Report In 2012, Ireland enjoyed its best year for foreign direct investment in more than a decade, and its prime minister has promised he'll make it the best small country to do business in by 2016. Have the Irish put their domestic economic crisis behind them? Will boosted infrastructure investment erase industry uncertainty? How will a price-cutting agreement with innovators and generic players change the playing field? Report includes key economic data and interviews. Expertly maneuver your way through government policies, business regulations and cultural nuances to launch your business in the growth markets of Brazil, China, Ireland, Colombia and Belgium. Focus Reports serves business professionals in the Pharmaceutical industry. The country reports offer a snapshot of the challenges and issues faced by an industry through the voice and insight of the decision makers at governmental, legislative and corporate levels. They are based on exclusive interviews conducted by our staff.